{
  "$schema": "https://themachinepress.com/schemas/story-v1.schema.json",
  "schema_version": "1.0.0",
  "document_type": "machine_press_story",
  "story": {
    "story_id": "mp-2026-07-23-010",
    "source_story_id": "tmp-story-nbcn2-structure-epilepsy-inhibitors",
    "edition_id": "mp-2026-07-23-morning-0014",
    "edition_url": "https://themachinepress.com/edition/2026-07-23",
    "position": 10,
    "story_type": "dispatch",
    "section": "research",
    "editorial_classification": "editorial",
    "headline": "A Brain Transporter Revealed Its Shape—and Its First Blockers",
    "slug": "a-brain-transporter-revealed-its-shape-and-its-first-blockers",
    "dek": "The first high-resolution NBCn2 structure guided compounds that reduced activity in tissue studies.",
    "summary": "The first high-resolution NBCn2 structure guided compounds that reduced activity in tissue studies.",
    "body_text": "Mount Sinai researchers resolved the high-resolution structure of NBCn2, a brain protein that regulates acid-base balance and has genetic links to epilepsy and other neurological conditions. The team also developed compounds that inhibited the transporter and reduced brain activity in tissue experiments. The work establishes a molecular tool and potential target, not a tested therapy.",
    "why_it_matters": "The first high-resolution NBCn2 structure guided compounds that reduced activity in tissue studies.",
    "limitations": [
      "The work establishes a molecular tool and potential target, not a tested therapy."
    ],
    "importance": 8,
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-23-010/a-brain-transporter-revealed-its-shape-and-its-first-blockers",
    "json_url": "https://themachinepress.com/story/mp-2026-07-23-010.json",
    "first_published_at": "2026-07-23T09:00:00.000-04:00",
    "modified_at": "2026-07-23T09:00:00.000-04:00",
    "content_status": "new",
    "is_carryover": false,
    "carryover_reason": null,
    "key_claims": [
      {
        "claim_id": "claim-mp-2026-07-23-010-001",
        "text": "The first high-resolution NBCn2 structure guided compounds that reduced activity in tissue studies.",
        "source_ids": [
          "source-2026-07-23-010"
        ],
        "qualification": "The work establishes a molecular tool and potential target, not a tested therapy."
      }
    ],
    "source_ids": [
      "source-2026-07-23-010"
    ],
    "tags": [
      "epilepsy",
      "protein structure",
      "drug discovery"
    ],
    "image_url": null,
    "corrections": []
  },
  "sources": [
    {
      "source_id": "source-2026-07-23-010",
      "title": "Mount Sinai via Newswise: NBCn2 structure and inhibitors",
      "publisher": "Mount Sinai Health System via Newswise",
      "url": "https://www.newswise.com/articles/study-reveals-structure-of-brain-protein-and-identifies-potential-drug-target-for-epilepsy-research",
      "canonical_url": "https://www.newswise.com/articles/study-reveals-structure-of-brain-protein-and-identifies-potential-drug-target-for-epilepsy-research",
      "source_type": "secondary_reporting",
      "is_primary_source": false,
      "published_at": null,
      "accessed_at": "2026-07-23T08:34:00.000-04:00",
      "supports_claim_ids": [
        "claim-mp-2026-07-23-010-001"
      ]
    }
  ],
  "corrections": [],
  "publisher": {
    "name": "The Machine Press",
    "url": "https://themachinepress.com",
    "description": "A daily newspaper for the age of artificial intelligence."
  },
  "cite_this_report": {
    "title": "A Brain Transporter Revealed Its Shape—and Its First Blockers",
    "publisher": "The Machine Press",
    "published_at": "2026-07-23T09:00:00.000-04:00",
    "canonical_url": "https://themachinepress.com/story/mp-2026-07-23-010/a-brain-transporter-revealed-its-shape-and-its-first-blockers"
  }
}